Tables: Adverse Events

Id Lesson SAS R SAS Video R Video
TFL_TAE_L100 Overview of Adverse Events
TFL_TAE_L101 Treatment emergent adverse events, by primary system organ class and preferred term
TFL_TAE_L102 Treatment-Emergent Adverse Events by Severity
TFL_TAE_L103 Treatment-Emergent Adverse Events by descending frequency
TFL_TAE_L103a Treatment-Emergent Adverse Events by descending frequency - SOC repeated on page
TFL_TAE_L103b Treatment-Emergent Adverse Events by descending frequency - SOC repeated - approach 2
TFL_TAE_L104 Treatment-Emergent Adverse Events by Relationship to Study Drug
TFL_TAE_L105 Treatment-Emergent Adverse Events by Preferred Term
TFL_TAE_L105a Treatment-Emergent Adverse Events by Preferred Term
TFL_TAE_L105a1 Treatment-Emergent Adverse Events by Preferred Term (descending frequency)
TFL_TAE_L106 TEAE That Equal to or Exceed a Threshold of 5% in Any Treatment Group
TFL_TAE_L107 Treatment-Emergent Adverse Events by Preferred Term - with fisher exact test p-value
TFL_TAE_L107a TEAE by PT - with chisq/fisher exact test p-value
TFL_TAE_L108 TEAE by PT - Odds Ratio
TFL_TAE_L108a TEAE by PT - Odds Ratio with p-value
TFL_TAE_L109 TEAE by PT - Risk Ratio
TFL_TAE_L110 TEAE by PT - Risk Difference
TFL_TAE_L111 Exposure Adjusted Event Rate by SOC and PT
TFL_TAE_L112 Exposure Adjusted Subject Incidence Rate by SOC and PT
TFL_TAE_L113 TEAE by SOC, PT and Grade